107 related articles for article (PubMed ID: 26837549)
21. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
23. Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives.
Cirello V; Gambale C; Nikitski AV; Masaki C; Roque J; Colombo C
Panminerva Med; 2024 Jun; 66(2):155-173. PubMed ID: 38576304
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated ("insular") carcinoma of the thyroid gland--two cases report.
Paik SS; Kim WS; Hong EK; Park MH; Lee JD
J Korean Med Sci; 1997 Feb; 12(1):70-4. PubMed ID: 9142665
[TBL] [Abstract][Full Text] [Related]
25. Current evidences in poorly differentiated thyroid carcinoma: a systematic review and subsection meta-analysis for clinical decision making.
Chatterjee S; Mair M; Shaha AR; Paleri V; Sawhney S; Mishra A; Bhandarkar S; D'Cruz AK
Endocrine; 2024 Mar; ():. PubMed ID: 38504051
[TBL] [Abstract][Full Text] [Related]
26. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
[TBL] [Abstract][Full Text] [Related]
27. Poorly Differentiated Thyroid Carcinoma: Single Centre Experience and Review of the Literature.
Bellini MI; Biffoni M; Patrone R; Borcea MC; Costanzo ML; Garritano T; Melcarne R; Menditto R; Metere A; Scorziello C; Summa M; Ventrone L; D'Andrea V; Giacomelli L
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830540
[TBL] [Abstract][Full Text] [Related]
28. Insular thyroid carcinoma in a young Moroccan man: Case report and review of the literature.
Abdellaoui W; Assarrar I; Benyakhlef S; Tahri A; Messaoudi N; Haloui A; Rouf S; Bennani A; Latrech H
Ann Med Surg (Lond); 2022 May; 77():103592. PubMed ID: 35638017
[TBL] [Abstract][Full Text] [Related]
29. Poorly differentiated thyroid carcinoma: a cytologic-histologic review.
Bongiovanni M; Sadow PM; Faquin WC
Adv Anat Pathol; 2009 Sep; 16(5):283-9. PubMed ID: 19700938
[TBL] [Abstract][Full Text] [Related]
30. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
31. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
Menon MP; Khan A
J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
[TBL] [Abstract][Full Text] [Related]
32. Histological and functional correlation of thyroid carcinoma by immunohistochemistry.
Prathiba D; Rao KR; Madhavan M
Indian J Pathol Microbiol; 1990 Jan; 33(1):35-40. PubMed ID: 2394474
[TBL] [Abstract][Full Text] [Related]
33. Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopic study of two cases.
Albores-Saavedra J; Sharma S
Mod Pathol; 2001 Feb; 14(2):98-104. PubMed ID: 11235911
[TBL] [Abstract][Full Text] [Related]
34. The story of poorly differentiated thyroid carcinoma: From Langhans' description to the Turin proposal via Juan Rosai.
Volante M; Bussolati G; Papotti M
Semin Diagn Pathol; 2016 Sep; 33(5):277-83. PubMed ID: 27344303
[TBL] [Abstract][Full Text] [Related]
35. Poorly Differentiated Thyroid Carcinoma: 10-Year Experience in a Southeast Asian Population.
Yu MG; Rivera J; Jimeno C
Endocrinol Metab (Seoul); 2017 Jun; 32(2):288-295. PubMed ID: 28685518
[TBL] [Abstract][Full Text] [Related]
36. Poorly differentiated carcinoma of the thyroid retrospective clinical and morphologic evaluation.
Hwang TS; Suh JS; Kim YI; Park SH; Koh CS; Cho BY; Oh SK
J Korean Med Sci; 1990 Mar; 5(1):47-52. PubMed ID: 2206466
[TBL] [Abstract][Full Text] [Related]
37. A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter.
Yasuoka H; Nakamura Y; Hirokawa M; Yoshida KI; Anno K; Tori M; Tsujimoto M
BMC Clin Pathol; 2017; 17():9. PubMed ID: 28588422
[TBL] [Abstract][Full Text] [Related]
38. An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule.
Yuang K; Al-Bahadili H; Chang A
JCEM Case Rep; 2023 May; 1(3):luad052. PubMed ID: 37908574
[TBL] [Abstract][Full Text] [Related]
39. Poorly differentiated "insular" carcinoma of the thyroid: a case report.
Yang HJ; King KL; Yang AH; Chu KP; Jap TS; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jul; 58(1):45-9. PubMed ID: 8870327
[TBL] [Abstract][Full Text] [Related]
40. Fine-needle aspiration of an unusual case of poorly differentiated insular carcinoma of the thyroid.
Gong Y; Krishnamurthy S
Diagn Cytopathol; 2005 Feb; 32(2):103-7. PubMed ID: 15637672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
